TD ASSET MANAGEMENT INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 139 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,107,400
-67.7%
370,857
-22.5%
0.02%
-66.0%
Q2 2023$43,611,939
+74.9%
478,726
+26.7%
0.05%
+66.7%
Q1 2023$24,930,769
+77.5%
377,968
+39.2%
0.03%
+76.5%
Q4 2022$14,045,470
-23.0%
271,620
-2.5%
0.02%
-26.1%
Q3 2022$18,231,000
+44.7%
278,716
+0.0%
0.02%
+53.3%
Q2 2022$12,603,000
+0.1%
278,712
+12.5%
0.02%
+25.0%
Q1 2022$12,585,000
+65.3%
247,686
+53.8%
0.01%
+100.0%
Q4 2021$7,614,000
+93.1%
161,045
+34.6%
0.01%
+50.0%
Q3 2021$3,944,000
-55.8%
119,664
-14.2%
0.00%
-55.6%
Q2 2021$8,920,000
+102.5%
139,402
+35.8%
0.01%
+80.0%
Q1 2021$4,404,000
+0.7%
102,623
+34.2%
0.01%0.0%
Q4 2020$4,373,000
+117.1%
76,443
+14.5%
0.01%
+66.7%
Q3 2020$2,014,000
-7.6%
66,7430.0%0.00%0.0%
Q2 2020$2,180,000
+160.5%
66,743
+113.6%
0.00%
+200.0%
Q1 2020$837,000
+20.1%
31,243
+37.2%
0.00%0.0%
Q4 2019$697,000
+27.2%
22,7650.0%0.00%0.0%
Q3 2019$548,000
+27.7%
22,765
+34.4%
0.00%0.0%
Q2 2019$429,000
+30.0%
16,9410.0%0.00%0.0%
Q1 2019$330,000
+26.0%
16,941
-14.6%
0.00%
Q4 2018$262,000
-24.3%
19,841
+2.1%
0.00%
-100.0%
Q3 2018$346,000
-19.2%
19,4410.0%0.00%0.0%
Q2 2018$428,00019,4410.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,160,000$163,403,60025.44%
Avoro Capital Advisors LLC 10,625,000$549,418,7508.21%
Logos Global Management LP 1,350,000$69,808,5008.18%
EcoR1 Capital, LLC 5,183,431$268,035,2178.16%
Saturn V Capital Management LP 212,329$9,414,3197.81%
ACUTA CAPITAL PARTNERS, LLC 217,500$11,246,9256.92%
Ghost Tree Capital, LLC 300,000$15,513,0006.62%
Finepoint Capital LP 334,890$17,3175.60%
Cormorant Asset Management, LP 1,576,872$81,5405.46%
Tri Locum Partners LP 221,897$11,474,0004.64%
View complete list of APELLIS PHARMACEUTICALS INC shareholders